glp-1 clinical trials Lilly orforglipron oral phase 3 weight loss trial What is a GLP-1? (And

In patients with type 2 diabetes mellitus (T2DM), insulin secretion is markedly decreased or absent [2], and GLP-1 receptor agonists (GLP-1 RA) have been shown to improve glycemic control in this population [3, 4]

In the SUSTAIN-6 clinical trial from 2016, patients taking GLP-1 drugs were nearly 1.5 times more likely to develop retinopathy complications than those in the placebo group

Disclosures F

In contrast, REWIND (dulaglutide) recruited participants with comparatively lower cardiovascular risk, as it had the lowest baseline mean HbA1c of 7.2% and only 31.5% had known CVD [57]

It's important to note that Rybelsus, being an oral formulation, does not cause injection site reactions

Commonly prescribed GLP-1 medications include Ozempic (semaglutide) , Mounjaro (tirzepatide) , and their generic alternatives